about
The biomarkers of immune dysregulation and inflammation response in Parkinson diseaseNutritional and Nanotechnological Modulators of MicrogliaTargeting innate immunity for neurodegenerative disorders of the central nervous systemPathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric DisordersCB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseTheoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's DiseaseGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesDocosahexaenoic Acid and Cognition throughout the LifespanPhosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and CognitionThe Role of Stefin B in Neuro-inflammationInnate Immune Response in Brain, NF-Kappa B Signaling and CystatinsBioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative DisordersIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyAlzheimer's Disease associated with Psychiatric ComorbiditiesElusive roles for reactive astrocytes in neurodegenerative diseasesLow-grade inflammation, diet composition and health: current research evidence and its translationHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesToll-Like Receptor 4 Deficiency Impairs Motor Coordination.Two-Photon Enzymatic Probes Visualizing Sub-cellular/Deep-brain Caspase Activities in Neurodegenerative ModelsExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsRecent Advances of the NLRP3 Inflammasome in Central Nervous System DisordersTargeting neuroinflammation in Alzheimer's diseaseOmega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's DiseaseCurrent and future implications of basic and translational research on amyloid-β peptide production and removal pathwaysThe ischemic environment drives microglia and macrophage functionNT-020 treatment reduces inflammation and augments Nrf-2 and Wnt signaling in aged ratsNLRP3 Inflammasome in Neurological Diseases, from Functions to TherapiesIntegrative analysis of 111 reference human epigenomesBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialActivation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviorsBehavioral and monoamine perturbations in adult male mice with chronic inflammation induced by repeated peripheral lipopolysaccharide administration.The pathogenesis of bornaviral diseases in mammals.Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degenerationProteomic anaysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response.Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.Endoplasmic reticulum stress and inflammation in the central nervous systemComputational modeling of cytokine signaling in microglia.Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorderPD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.Inflammasomes as therapeutic targets for Alzheimer's disease.
P2860
Q26738459-9C2D06AA-D156-4B63-BE5A-AFDB443FBA5DQ26740644-C569602D-7754-4C87-932F-FEC886477382Q26744219-616B8065-F3B5-406F-8A9E-0271E94D1C27Q26745690-5AECD83D-0FF3-4E4B-9288-2519CECAC2EFQ26746050-4EE77B73-5344-492B-8DDA-D8EFB8362716Q26746174-E7B09469-5AFD-4C0A-AC43-01632B5A0ACFQ26767289-90BD4C46-DF3C-41BD-9E37-1FD0F8A3F37BQ26768442-169098DD-1C98-4696-8CFA-895577FE76D3Q26771954-D80DD38B-2164-4612-90E9-666729AFCC96Q26773156-9D5DB303-AE07-4215-9A91-56F4A65191F7Q26773162-592AB57E-677B-42B7-A3CC-E8972C02CD89Q26774418-F316C8D0-44FE-4261-A0BF-A3C4C9A8CE5BQ26775404-E2B068BE-7260-4453-A8F4-EB2E571D1E68Q26796602-0A5C46CA-28E6-486B-A6AA-58004A1BE038Q26797399-21263C0C-6E27-4670-B063-C727B2447081Q26801350-13031FDE-0CED-479B-B8CA-FE76E625699CQ27015965-4D741E92-87B0-4DF0-9F6B-A58003A7AF17Q27313529-6963A940-0599-4EB5-8189-B0DEC519B74DQ27313654-9F1F4D61-19CA-41E3-934A-C7293CD0E809Q28075692-A4F1B9DF-8FB0-4F77-A436-EAB6201009CEQ28076650-E21D80AF-1005-4F0B-BD21-3750C2A20116Q28078474-726E69E6-C114-4B9F-BFC2-89B7B0761C08Q28080464-CD393307-A2E1-4CAC-9C95-E0A6A59FA7EEQ28081678-175588E2-AFF7-4E5C-8299-BA059E8409E2Q28086874-31BCD9BA-1DEB-4B8D-BA9E-6E3714FBCA7AQ28388958-1EB70CA5-7551-4E2F-BD3E-19F64FB451F1Q29248417-8D44D2D7-B645-4B73-856E-B672954880B4Q29615565-84E57482-7968-4FD5-8194-15674253F113Q29994589-76063341-4A13-456F-B3EF-E0596AAFB49FQ29994732-C4F0CF93-D8EF-400F-B285-009F571232D1Q30719160-7EF04E4F-3A5F-4972-9FA1-80DE5A565A8EQ31099562-D243BEFB-5C72-4308-BDE3-2F51BB99F787Q33563621-EAC945FF-646C-42AB-B8A1-195883CD7DFFQ33634674-55BAF1A6-8A0D-4296-836E-3CD8B10CA645Q33729341-E2AD45A5-F580-4048-B5F8-544F3CEDA5F2Q33730922-50A3D861-EB5C-4680-B5AF-0D6A3ECE3DDEQ33922131-4DB088F0-7AA6-45AF-90AF-F010B111F153Q34265484-50500847-B11A-422B-8AA3-8DE454622BA3Q34509539-3DDDF2D3-F192-4052-8A19-8AB24519500DQ34547897-EFEFDD91-B055-422C-A969-6C37F843929B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Innate immune activation in neurodegenerative disease.
@en
type
label
Innate immune activation in neurodegenerative disease.
@en
prefLabel
Innate immune activation in neurodegenerative disease.
@en
P2093
P2860
P356
P1476
Innate immune activation in neurodegenerative disease.
@en
P2093
Eicke Latz
Markus P Kummer
Michael T Heneka
P2860
P304
P356
10.1038/NRI3705
P577
2014-07-01T00:00:00Z